Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Pancreatic Ductal | 4 | 2025 | 168 | 1.980 |
Why?
|
| Pancreatic Neoplasms | 4 | 2025 | 728 | 1.480 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2025 | 175 | 1.280 |
Why?
|
| Tubulin | 1 | 2024 | 76 | 0.890 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2024 | 73 | 0.850 |
Why?
|
| Immunotherapy | 1 | 2024 | 748 | 0.610 |
Why?
|
| Brain Neoplasms | 2 | 2025 | 1409 | 0.540 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 1541 | 0.510 |
Why?
|
| Mutation | 3 | 2025 | 6248 | 0.450 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2024 | 133 | 0.420 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 1347 | 0.260 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 7111 | 0.250 |
Why?
|
| CD24 Antigen | 1 | 2025 | 33 | 0.240 |
Why?
|
| Liquid Biopsy | 1 | 2025 | 16 | 0.230 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2025 | 998 | 0.230 |
Why?
|
| Foreign Medical Graduates | 1 | 2024 | 12 | 0.220 |
Why?
|
| Vaccines, DNA | 1 | 2025 | 49 | 0.220 |
Why?
|
| Hematology | 1 | 2024 | 43 | 0.220 |
Why?
|
| Cell Line, Tumor | 4 | 2025 | 3697 | 0.210 |
Why?
|
| B7-H1 Antigen | 1 | 2024 | 126 | 0.210 |
Why?
|
| Colitis | 1 | 2025 | 164 | 0.200 |
Why?
|
| Biological Products | 1 | 2025 | 134 | 0.200 |
Why?
|
| Medical Oncology | 1 | 2024 | 243 | 0.200 |
Why?
|
| CRISPR-Cas Systems | 1 | 2024 | 293 | 0.180 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 520 | 0.180 |
Why?
|
| Nanoparticles | 1 | 2025 | 288 | 0.180 |
Why?
|
| Lipids | 1 | 2025 | 562 | 0.180 |
Why?
|
| Aged | 5 | 2025 | 21379 | 0.170 |
Why?
|
| Gastrointestinal Diseases | 1 | 2024 | 359 | 0.170 |
Why?
|
| Phosphoglycerate Kinase | 1 | 2019 | 7 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 816 | 0.160 |
Why?
|
| DNA | 1 | 2025 | 1484 | 0.150 |
Why?
|
| Middle Aged | 5 | 2025 | 28888 | 0.150 |
Why?
|
| Glycolysis | 1 | 2019 | 167 | 0.150 |
Why?
|
| Adult | 5 | 2025 | 31618 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 256 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 742 | 0.140 |
Why?
|
| Prognosis | 2 | 2025 | 5009 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 2064 | 0.130 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 1683 | 0.120 |
Why?
|
| Humans | 11 | 2025 | 132334 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2019 | 374 | 0.120 |
Why?
|
| Mice | 4 | 2025 | 18571 | 0.110 |
Why?
|
| Glucose | 1 | 2019 | 911 | 0.110 |
Why?
|
| Female | 7 | 2025 | 70786 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 332 | 0.110 |
Why?
|
| Histones | 1 | 2018 | 538 | 0.110 |
Why?
|
| Male | 5 | 2025 | 65052 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2025 | 17363 | 0.090 |
Why?
|
| Animals | 4 | 2025 | 34989 | 0.090 |
Why?
|
| Neoplasms | 1 | 2024 | 2944 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2018 | 2494 | 0.070 |
Why?
|
| Liposomes | 1 | 2025 | 203 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2025 | 449 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2024 | 725 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2019 | 2512 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 688 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2025 | 4725 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2024 | 778 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 2453 | 0.040 |
Why?
|
| Survival Rate | 1 | 2024 | 2187 | 0.040 |
Why?
|
| Tyrosine | 1 | 2019 | 153 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 249 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 275 | 0.040 |
Why?
|
| Genes, cdc | 1 | 2018 | 25 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 757 | 0.030 |
Why?
|
| Acetylation | 1 | 2018 | 192 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2018 | 143 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2018 | 240 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 1052 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 796 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2019 | 1615 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 1294 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 6455 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11627 | 0.020 |
Why?
|